CT is currently the gold standard in radiation therapy treatment planning. MRI provides a number of advantages over CT, including improved accuracy of target delineation, reduced radiation exposure, and simplified clinical workflow. There are two major technical hurdles that are impeding the clinical adoption of MRI-based radiation treatment planning: (1) geometric distortion, and (2) lack of electron density information. The goal of this project is to develop novel image analysis and computational tools to enable MRI-based radiation treatment planning. We hypothesize that accurate patient geometry and electron density information can be derived from MRI if the appropriate MR image acquisition, reconstruction, and analysis methods are applied.
In Aim 1, we will improve the geometric accuracy of MRI by minimizing system-level and patient- specific distortions. To maintain sufficient system-level accuracy, we will perform comprehensive machine- specific calibrations and ongoing quality assurance procedures. To correct patient-induced distortions, we will develop novel computational tools to derive a detailed magnetic field distortion map based on physical principles, which is used to correct susceptibility-induced spatial distortions.
In Aim 2, we will develop a unifying Bayesian method for quantitative electron density mapping, by combining the complementary intensity and geometry information. By utilizing multiple patient atlases and panoramic, multi-parametric MRI with differential contrast, we will apply machine learning techniques to encode the information given by intensity and geometry into two conditional probability density functions. These will be combined into one unifying posterior probability density function, which provides the optimal electron density on a continuous scale.
In Aim 3, we will clinically evaluate the geometric and dosimetric accuracy of MRI for treatment planning in terms of 3 primary end points: (1) organ contours, (2) patient setup based on reference images, and (3) 3D dose distributions (both photon and proton), using CT as the ground truth. These evaluations will be conducted through patient studies at multiple disease sites, including brain, head and neck, and prostate. Success of the project will afford distortion-free MRI with reliable, quantitative electron density information. This will pave the way for MRI-based radiation treatment planning, leading to an improved accuracy in the overall radiation therapy process. It will streamline the treatment workflow for the MRI-guided radiation delivery systems under active development. With minimal modification, the proposed techniques can be applied to MR-based PET attenuation correction in PET/MR imaging. More broadly, the unifying Bayesian formalism can be used to improve current imaging biomarkers by integrating a wide variety of disparate information including anatomical and functional imaging such as perfusion/diffusion-weighted imaging and MR spectroscopic imaging. It will facilitate the incorporation of multimodality MRI into the entire process of cancer management: diagnosis, staging, radiation treatment planning, and treatment response assessment.

Public Health Relevance

The goal of this project is to develop novel image analysis and computational tools to enable MRI-based radiation therapy treatment planning. Success of the project will overcome the major technical hurdles in the use of MRI in radiation therapy and will afford distortion-free MRI with reliable, quantitative electron density information. It will pve the way for MRI-based radiation treatment planning, leading to an improved accuracy in the overall radiation therapy process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA193730-04
Application #
9624738
Study Section
Radiation Therapeutics and Biology Study Section (RTB)
Program Officer
Zhang, Huiming
Project Start
2016-02-01
Project End
2021-01-31
Budget Start
2019-02-01
Budget End
2020-01-31
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Stanford University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Wu, Jia; Cao, Guohong; Sun, Xiaoli et al. (2018) Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy. Radiology 288:26-35
Wu, Jia; Li, Xuejie; Teng, Xiaodong et al. (2018) Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer. Breast Cancer Res 20:101
Lee, Juheon; Cui, Yi; Sun, Xiaoli et al. (2018) Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC. Eur Radiol 28:736-746
Ren, Shangjie; Hara, Wendy; Wang, Lei et al. (2017) Robust Estimation of Electron Density From Anatomic Magnetic Resonance Imaging of the Brain Using a Unifying Multi-Atlas Approach. Int J Radiat Oncol Biol Phys 97:849-857
Wu, Jia; Cui, Yi; Sun, Xiaoli et al. (2017) Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways. Clin Cancer Res 23:3334-3342
Wu, Jia; Li, Bailiang; Sun, Xiaoli et al. (2017) Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer. Radiology 285:401-413
Wu, Jia; Sun, Xiaoli; Wang, Jeff et al. (2017) Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation. J Magn Reson Imaging 46:1017-1027
Wu, Jia; Gensheimer, Michael F; Dong, Xinzhe et al. (2016) Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study. Int J Radiat Oncol Biol Phys 95:1504-1512
Wu, Jia; Gong, Guanghua; Cui, Yi et al. (2016) Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy. J Magn Reson Imaging 44:1107-1115